newsfilter
← Latest News
ACCESS Newswire·

Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule

KELOWNA, BC / ACCESS Newswire / June 25, 2026 / Lexaria Bioscience Corp. , a global innovator in drug delivery platforms, announces that dosing began on schedule